cognitive cybersecurity intelligence
The patent for Insmed Inc.’s drug, ARIKAYCE KIT, is set to expire on April 8, 2024. The drug, which is marketed by Insmed and included in one NDA, is available from a single supplier.
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Forensic investigation continues into IntraCare cybersecurity breach nzdoctor.co.nz
Microsoft’s terms of service for its Copilot AI assistant include a notable disclaimer that has sparked renewed scrutiny from security and enterprise communities: the product
FBI Warns Of AVrecon Malware Targeting Network Devices Across 163 Countries – The Cyber Express The Cyber Express
NATO to launch new cyber center by 2028: Official Breaking Defense
